ストックスクリーナーアプリを入手
3.20
1.91%
0.06
アフターアワーズ：
3.20
前日終値:
$3.14
開ける：
$3.15
24時間の取引高:
1.08M
Relative Volume:
2.65
時価総額：
$84.33M
収益：
$18.94M
当期純損益:
$-2.71M
株価収益率:
-22.86
EPS:
-0.14
ネットキャッシュフロー:
$-4.92M
1週間 パフォーマンス:
+32.23%
1か月 パフォーマンス:
+74.86%
6か月 パフォーマンス:
+142.42%
1年 パフォーマンス:
+137.04%
1日の値動き範囲:
$2.86
$3.3398
1週間の範囲:
$2.475
$3.78
52週間の値動き範囲:
$1.18
$3.78
Icad Inc Stock (ICAD) Company Profile
ICAD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
3.20 | 84.33M | 18.94M | -2.71M | -4.92M | -0.14 |
|
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-01-18 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-04-22 | 開始されました | Guggenheim | Buy |
| 2021-03-23 | 開始されました | BTIG Research | Buy |
| 2021-02-26 | 開始されました | Oppenheimer | Outperform |
| 2021-01-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 開始されました | B. Riley Securities | Buy |
| 2020-02-05 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-01-09 | 開始されました | Lake Street | Buy |
| 2008-12-09 | 繰り返されました | Canaccord Adams | Buy |
| 2008-08-01 | 繰り返されました | MDB Capital Group | Buy |
| 2008-05-14 | 繰り返されました | Canaccord Adams | Buy |
| 2008-02-14 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
| 2007-01-24 | 繰り返されました | Dawson James | Speculative Buy |
すべてを表示
Icad Inc (ICAD) 最新ニュース
iCAD, Inc. (NASDAQ:ICAD) Short Interest Down 14.5% in January - MarketBeat
Earnings call transcript: iCAD Q3 2024 sees revenue rise, SaaS shift - MSN
StockNews.com Downgrades iCAD (NASDAQ:ICAD) to Sell - MarketBeat
Why ICAD Stock Is Climbing Today - MSN
iCAD, Inc. Pre-Announces Estimated Q4 2024 Revenue - Defense World
iCAD stock soars to 52-week high, reaching $2.67 amid robust gains - MSN
After Leaping 46% iCAD, Inc. (NASDAQ:ICAD) Shares Are Not Flying Under The Radar - Simply Wall St
iCAD Shares Climb After 4Q Sales Guidance Beats Expectations - MarketWatch
ICAD, Inc. Provides Earnings Guidance for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
iCAD Pre-Announces Estimated Q4 2024 Revenue - GlobeNewswire
iCAD Reports Strong Q4: 106 Deals Closed, T-ARR Grows 11% to $9.8M - StockTitan
Zacks Market Edge Highlights: FiscalNote, and iCAD - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Sees Significant Decline in Short Interest - MarketBeat
Discover the AI Stocks Under $5 That Investors Are Talking About - Kuhinje EWE Daily
2 AI Stocks Under $5 - Yahoo Finance
Strategic Acquisitions by Hologic and iCAD Shape Future of CAD Market - openPR
iCAD (NASDAQ:ICAD) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
iCAD (NASDAQ:ICAD) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
FDA Clears iCAD’s ProFound Detection Version 4.0 - MPO-mag
iCAD (NASDAQ:ICAD) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Head-To-Head Comparison: iCAD (NASDAQ:ICAD) & Todos Medical (OTCMKTS:TOMDF) - Defense World
iCAD (NASDAQ:ICAD) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
New Research Addresses Image Based AI-Risk, Detection and Breast Arterial Calcifications Assessment - Imaging Technology News
iCAD (NASDAQ:ICAD) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
SABCS 2024: New Research Assesses iCAD’s Image Based - GlobeNewswire
iCAD's AI Breast Cancer Detection Breakthrough: New Research Shows Superior Risk Assessment Performance - StockTitan
CORRECTION – iCAD Advances Fight Against Breast Cancer with - GlobeNewswire
iCAD's New AI Breakthrough Boosts Breast Cancer Detection by 23%, Partners with Cascaid Health - StockTitan
US Penny Stocks To Watch In December 2024 - Simply Wall St
Breast Cancer Brachytherapy Market Growth in Future Scope - openPR
Global Computer-Aided Detection (CAD) Software Market Size, - openPR
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024 - The Manila Times
iCAD Advances Fight Against Breast Cancer with FDA-cleared, - GlobeNewswire
iCAD's New AI Cancer Detection System Boosts Accuracy by 22%, Partners with Cascaid Health | ICAD Stock News - StockTitan
U.S. Computer-Aided Detection (CAD) Market Future Business - openPR
Computer Aided Detection (CAD) Market: Expected Positive - openPR
Need To Know: Analysts Just Made A Substantial Cut To Their iCAD, Inc. (NASDAQ:ICAD) Estimates - Yahoo Finance
iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Q3 2024 Earnings Call Transcript - Insider Monkey
iCAD (NASDAQ:ICAD) Rating Lowered to “Sell” at StockNews.com - Defense World
ICAD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings call: iCAD reports steady growth with SaaS transition By Investing.com - Investing.com Canada
Q3 2024 ICAD Inc Earnings Call - Cbainfo
iCad Inc. (ICAD) Quarterly 10-Q Report - Quartzy
Icad: Q3 Earnings Snapshot - New Haven Register
icad Inc (ICAD) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Strategic Shifts - Yahoo Finance
iCAD, Inc. Reports Growth in ARR and Revenue - TipRanks
iCAD reports Q3 adjusted EPS (7c), consensus (8c) - TipRanks
iCAD Inc Reports Q3 2024 Revenue of $4.2 Million, EPS Loss of $0 - GuruFocus.com
Icad Inc (ICAD) 財務データ
収益
当期純利益
現金流量
EPS
0.47%
大文字化:
|
ボリューム (24 時間):